...
首页> 外文期刊>BMC Medical Genetics >Weighted correlation network and differential expression analyses identify candidate genes associated with BRAF gene in melanoma
【24h】

Weighted correlation network and differential expression analyses identify candidate genes associated with BRAF gene in melanoma

机译:加权相关网络和差异表达分析鉴定了黑色素瘤中与BRAF基因相关的候选基因

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Primary cutaneous malignant melanoma is a cancer of the pigment cells of the skin, some of which are accompanied by BRAF mutation. Melanoma incidence and mortality rates have been rising around the world. As the current knowledge about pathogenesis, clinical and genetic features of cutaneous melanoma is not very clear, we aim to use bioinformatics to identify the potential key genes involved in the expression and mutation status of BRAF. Firstly, we used UCSC public hub datasets of melanoma (Lin et al., Cancer Res 68(3):664, 2008) to perform weighted genes co-expression network analysis (WGCNA) and differentially expressed genes analysis (DEGs), respectively. Secondly, overlapping genes between significant gene modules and DEGs were screened and validated at transcriptional levels and overall survival in TCGA and GTEx datasets. Lastly, the functional enrichment analysis was accomplished to find biological functions on the web-server database. We performed weighted correlation network and differential expression analyses, using gene expression data in melanoma samples. We identified 20 genes whose expression was correlated with the mutation status of BRAF. For further validation, three of these genes (CYR61, DUSP1, and RNASE4) were found to have similar expression patterns in skin tumors from TCGA compared with normal skin samples from GTEx. We also found that weak expression of these three genes was associated with worse overall survival in the TCGA data. These three genes were involved in the nucleic acid metabolic process. In this study, CYR61, DUSP1, and RNASE4 were identified as potential genes of interest for future molecular studies in melanoma, which would improve our understanding of its causes and underlying molecular events. These candidate genes may provide a promising avenue of future research for therapeutic targets in melanoma.
机译:原发性皮肤恶性黑色素瘤是皮肤色素细胞的癌症,其中一些伴有BRAF突变。黑色素瘤的发病率和死亡率在世界范围内一直在上升。由于关于皮肤黑色素瘤的发病机理,临床和遗传特征的当前知识尚不十分清楚,我们旨在利用生物信息学来鉴定参与BRAF表达和突变状态的潜在关键基因。首先,我们使用黑色素瘤的UCSC公共中心数据集(Lin等,Cancer Res 68(3):664,2008)分别进行加权基因共表达网络分析(WGCNA)和差异表达基因分析(DEGs)。其次,在TCGA和GTEx数据集中,在转录水平和总体存活率上筛选并验证了重要基因模块和DEG之间的重叠基因。最后,完成了功能增强分析,以在网络服务器数据库上找到生物学功能。我们使用黑色素瘤样品中的基因表达数据进行了加权相关网络和差异表达分析。我们鉴定了20个基因的表达与BRAF突变状态相关的基因。为了进一步验证,发现这些基因中的三个(CYR61,DUSP1和RNASE4)与来自GTEx的正常皮肤样本相比在TCGA的皮肤肿瘤中具有相似的表达模式。我们还发现,这三个基因的弱表达与TCGA数据中较差的总体存活率有关。这三个基因参与了核酸代谢过程。在这项研究中,CYR61,DUSP1和RNASE4被确定为黑色素瘤未来分子研究的潜在潜在基因,这将增进我们对其原因和潜在分子事件的了解。这些候选基因可能为黑素瘤治疗靶标的未来研究提供有希望的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号